[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-PBM":3,"homepage-market-summary":30,"stock-news-PBM":172},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":14},"PBM","2026-10-07",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":9,"founded":9,"is_fund":13,"issuer":9,"category":9},"Psyence Biomedical Ltd. Common Shares","Nasdaq",null,"Common Stock","Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.","12",false,{"close":15,"open":16,"high":17,"low":18,"prev_close":19,"change":20,"percent_change":21,"volume":22,"transactions":23,"vwap":24,"high_52w":25,"low_52w":26,"avg_volume_52w":27,"range_52w_percent":28,"record_count":29},4.88,4.93,5.1,4.835,5.02,-0.14,-2.79,16199.021787,257,4.9156,175.78125,1.92,728679.7035283307,1.7,1210,{"status":31,"indices":32,"watchlist":75,"sectors":97,"benchmarks":152},"success",[33,40,47,54,60,67],{"symbol":34,"name":35,"price":36,"change":37,"pct_change":38,"is_up":13,"sparkline":39,"date":5},"SPX","S&P 500",7801.77,-17.16,-0.22,"0.0,13.9 2.3,10.5 4.6,12.4 6.9,14.2 9.3,16.0 11.6,11.5 13.9,10.8 16.2,4.8 18.5,4.8 20.8,7.9 23.2,8.0 25.5,6.0 27.8,9.1 30.1,9.8 32.4,10.8 34.7,10.0 37.1,7.0 39.4,4.4 41.7,2.0 44.0,2.9",{"symbol":41,"name":42,"price":43,"change":44,"pct_change":45,"is_up":13,"sparkline":46,"date":5},"NDX","NASDAQ 100",31160.08,-64.4,-0.21,"0.0,15.0 2.3,13.4 4.6,14.8 6.9,16.0 9.3,16.0 11.6,12.9 13.9,11.7 16.2,6.5 18.5,5.0 20.8,6.6 23.2,6.6 25.5,5.8 27.8,7.8 30.1,7.4 32.4,7.0 34.7,6.4 37.1,4.6 39.4,2.9 41.7,2.0 44.0,2.4",{"symbol":48,"name":49,"price":50,"change":51,"pct_change":52,"is_up":13,"sparkline":53,"date":5},"DJI","DOW JONES",51180,-341,-0.66,"0.0,6.3 2.3,2.0 4.6,3.3 6.9,6.0 9.3,11.3 11.6,8.7 13.9,9.5 16.2,6.4 18.5,8.0 20.8,10.9 23.2,12.3 25.5,8.2 27.8,11.2 30.1,12.3 32.4,16.0 34.7,15.8 37.1,13.7 39.4,13.0 41.7,10.8 44.0,13.7",{"symbol":55,"name":56,"price":57,"change":58,"pct_change":38,"is_up":13,"sparkline":59,"date":5},"COMP","NASDAQ Composite",27538.69,-61.2,"0.0,15.1 2.3,12.9 4.6,14.2 6.9,16.0 9.3,16.0 11.6,12.2 13.9,11.3 16.2,6.1 18.5,5.1 20.8,7.7 23.2,7.7 25.5,6.6 27.8,8.7 30.1,8.9 32.4,8.4 34.7,8.3 37.1,5.5 39.4,3.1 41.7,2.0 44.0,2.5",{"symbol":61,"name":62,"price":63,"change":64,"pct_change":65,"is_up":13,"sparkline":66,"date":5},"RUT","RUSSELL 2000",2777,-36.4,-1.29,"0.0,3.5 2.3,2.0 4.6,4.2 6.9,6.7 9.3,8.2 11.6,6.3 13.9,8.0 16.2,6.1 18.5,4.1 20.8,10.7 23.2,11.0 25.5,10.7 27.8,13.1 30.1,14.4 32.4,15.8 34.7,14.3 37.1,11.2 39.4,8.9 41.7,11.4 44.0,16.0",{"symbol":68,"name":69,"price":70,"change":71,"pct_change":72,"is_up":73,"sparkline":74,"date":5},"VIX","CBOE VIX",15.08,0.07,0.47,true,"0.0,2.0 2.3,9.7 4.6,4.9 6.9,4.5 9.3,2.5 11.6,11.3 13.9,13.7 16.2,13.5 18.5,16.0 20.8,12.3 23.2,10.4 25.5,13.5 27.8,8.8 30.1,8.9 32.4,7.8 34.7,7.6 37.1,11.8 39.4,10.9 41.7,12.9 44.0,12.6",[76,83,90],{"symbol":77,"name":78,"price":79,"change":80,"pct_change":81,"is_up":13,"sparkline":82,"date":5},"NVDA","NVIDIA Corp",237.36,-1.88,-0.79,"0.0,16.0 7.3,14.6 14.7,11.8 22.0,8.2 29.3,2.4 36.7,2.0 44.0,4.2",{"symbol":84,"name":85,"price":86,"change":87,"pct_change":88,"is_up":73,"sparkline":89,"date":5},"AAPL","Apple Inc",336.67,3.04,0.91,"0.0,16.0 7.3,9.0 14.7,14.2 22.0,7.7 29.3,9.3 36.7,7.9 44.0,2.0",{"symbol":91,"name":92,"price":93,"change":94,"pct_change":95,"is_up":13,"sparkline":96,"date":5},"TSLA","Tesla Inc",377.75,-2.93,-0.77,"0.0,16.0 7.3,15.0 14.7,15.4 22.0,7.1 29.3,3.0 36.7,2.0 44.0,3.5",[98,103,108,113,118,123,128,133,138,142,147],{"name":99,"etf":100,"change":101,"price":102,"is_up":13},"Technology","XLK",-0.3,201.39,{"name":104,"etf":105,"change":106,"price":107,"is_up":13},"Financials","XLF",-0.48,53.75,{"name":109,"etf":110,"change":111,"price":112,"is_up":73},"Healthcare","XLV",1.03,168.81,{"name":114,"etf":115,"change":116,"price":117,"is_up":13},"Consumer Cycl","XLY",-0.32,111.36,{"name":119,"etf":120,"change":121,"price":122,"is_up":13},"Consumer Staples","XLP",-0.12,81.7,{"name":124,"etf":125,"change":126,"price":127,"is_up":13},"Energy","XLE",-0.58,63.38,{"name":129,"etf":130,"change":131,"price":132,"is_up":13},"Industrials","XLI",-2.18,167.84,{"name":134,"etf":135,"change":136,"price":137,"is_up":13},"Materials","XLB",-1.51,48.98,{"name":139,"etf":140,"change":65,"price":141,"is_up":13},"Real Estate","XLRE",40.57,{"name":143,"etf":144,"change":145,"price":146,"is_up":13},"Utilities","XLU",-0.02,41.15,{"name":148,"etf":149,"change":150,"price":151,"is_up":13},"Comm Services","XLC",-0.35,111.26,[153,158,163,168],{"ticker":154,"name":155,"price":156,"change":157,"is_up":13},"SPY","SPDR S&P 500 ETF",777.22,-0.24,{"ticker":159,"name":160,"price":161,"change":162,"is_up":13},"QQQ","Invesco QQQ Trust",757.73,-0.25,{"ticker":164,"name":165,"price":166,"change":167,"is_up":13},"DIA","SPDR Dow Jones ETF",511.02,-0.69,{"ticker":169,"name":170,"price":171,"change":65,"is_up":13},"IWM","iShares Russell 2000",277.7,{"ticker":4,"count":173,"articles":174},20,[175,181,187,193,199,205,211,216,221,226,231,236,241,246,251,256,261,266,272,278],{"title":176,"link":177,"pubDate":178,"description":179,"source":180},"A Texas drugmaker says it holds about half the U.S. quota for a drug studied for addiction. Psyence partnered with it. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivAFBVV95cUxOVEtoalhUcm5mM2dxajJUMXBHaGRHaXdodlR6V2x1ekxHbkVNWDRSNU1CaGtBN1JyUUhwMnBLRTdHbUZmd1F6d05vZFNQLURfV2k4S3pKdmFDNVJzay1XcERTbXIzYjFiMW4tYm12aXRjcTdPdWl1OTE1akZ4RXhjMXp6eWYySTFjWXctci1sUEVrYzVTeVF3RFpJU293NWF5MHZORkk5cWdTUnJoc3RQVWJQY2Z0Nk5Wc1lRRQ?oc=5","Mon, 05 Oct 2026 11:00:00 GMT","A Texas drugmaker says it holds about half the U.S. quota for a drug studied for addiction. Psyence partnered with it. Stock Titan","Stock Titan",{"title":182,"link":183,"pubDate":184,"description":185,"source":186},"How PBM Reform Is Reshaping the Operational Environment for Pharma Manufacturers - Pharmaceutical Commerce","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwgFBVV95cUxPLVRsc1pSVXNrMTBuOTZkdC1ISXViQ0doR1pvUHNsdjJKak9YN0JhUnJrTnJKSGtKdjFhYjNBYmNOSjQ2Z3Fpb3R3cm1QSWphMDBfdnNVVktSWThwQy1YSU5fY1RSdUd1Qm84QktwYTd4eExxRFVoeGwtWHdRUG1ZUXR3eklMN1pMbXo5Si1yXzctLUgtRGExMXpUVjNLWmY5YkNFR2MtLXZYYjZXRW1mWUJRYjVndFYzeDVNQ1U2VzhCQQ?oc=5","Thu, 01 Oct 2026 15:25:21 GMT","How PBM Reform Is Reshaping the Operational Environment for Pharma Manufacturers Pharmaceutical Commerce","Pharmaceutical Commerce",{"title":188,"link":189,"pubDate":190,"description":191,"source":192},"Should CVS Health (CVS) Investors Worry About Its Care Push And PBM Scrutiny? - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Thu, 01 Oct 2026 16:40:33 GMT","Should CVS Health (CVS) Investors Worry About Its Care Push And PBM Scrutiny? Simply Wall Street","Simply Wall Street",{"title":194,"link":195,"pubDate":196,"description":197,"source":198},"Smart Ring Maker Oura Delays IPO Due to Market ‘Uncertainty’ - Modern Healthcare","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMifkFVX3lxTFBJZGhJUkc3a0JNbXFCUVFYd3ZvdWdMS1FEUXhNcndKQ3V6c2xpMW82X0EzZHcyb0ZYeWtUWTRSS0xJR0ZxX2xpc2V3M2NNVGRFajlnNEJBeml1OFlHRmZlMEZVWkpyR3htcUZjWDV5MldQaTFza3EwYThQcS1Vdw?oc=5","Tue, 29 Sep 2026 11:48:00 GMT","Smart Ring Maker Oura Delays IPO Due to Market ‘Uncertainty’ Modern Healthcare","Modern Healthcare",{"title":200,"link":201,"pubDate":202,"description":203,"source":204},"Regeneron and Sanofi Expand Antibody Alliance with Four New Drugs - Pharmaceutical Executive","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMikAFBVV95cUxOOEt3Z2RlbGhPQzVvaVVRRGhjTWR6dlJYcG1kMFY5dEU3V2lHMXF0X05BNW5wbGtwdjg0ZktfUi1PSkhtZktRQXNURFhIdmRJd0V0WWZZVkFmcEZFalRGMnVwNGg0RFBOU2JrT01tMl9VQnBxTGU4LWtCVjVPQW14ZEJQQklydHdfSndtclZXZm0?oc=5","Thu, 01 Oct 2026 14:48:47 GMT","Regeneron and Sanofi Expand Antibody Alliance with Four New Drugs Pharmaceutical Executive","Pharmaceutical Executive",{"title":206,"link":207,"pubDate":208,"description":209,"source":210},"Insurer-owned PBMs lose ground in commercial plan market - BenefitsPRO","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMinAFBVV95cUxPTkxOYzlFWlFJd1NqdzVvVDdQMXQyWUJoU2FZMHRzYzlGVXpqRC14WlVfN0FNbUM4Q0pETlkzM2dQSDFiWmVHM05uR0N5QWlMb2NRVXZDRzh1U2FsdkRfeGVySy04OHRRaUktTXBUR0pURnpmUnRPdVNib1lGUUR2NENOdWdwdEdRNVc5eFdmeXIyTkhZdENTTHh0bS0?oc=5","Tue, 06 Oct 2026 15:24:27 GMT","Insurer-owned PBMs lose ground in commercial plan market BenefitsPRO","BenefitsPRO",{"title":212,"link":213,"pubDate":214,"description":215,"source":180},"A passive holder reports more than 5% of Psyence Biomedical (PBM) common shares. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixwFBVV95cUxQdTgzemdyb2NLckptSnBtVDRXZGIzTVhLUkRFODdScFhqbUNONEZsbU81R2pKcUZVNGhweDc3Zk5pYTNibEZlSHJBQWdmb1NxNkVOMUhqUHNFMU94VkxRanMwdmlCNWxUNTdFd1FHQ0h2YVBtMHhEcHlMWEFwdXJORWNzbjBtOHJUXzJSUVVJajBuQU5vbl8zT3hseHQzNFA3RXVNZDhseERKa1BSS0J0LWNDYnUzX1RGMGJRYktoWUd3TWg0NTc0?oc=5","Mon, 05 Oct 2026 13:41:11 GMT","A passive holder reports more than 5% of Psyence Biomedical (PBM) common shares. Stock Titan",{"title":217,"link":218,"pubDate":219,"description":220,"source":186},"Why Waltz Health, Fresenius Kabi Are Taking Biosimilars Direct - Pharmaceutical Commerce","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiqAFBVV95cUxQQzBGVXEzWFJSNmpNZUFTM0dfeXhUeEp5ZWJRaF9nemF2bVk0Uzl6RUdMcFhXdG14ZTlreW1GZkoyUUhkbjdGZ3pGU0xPMF80SDZwNXlYVXNTdXdseEdDWEdfV254VjZEMEtWTHJHUEdiYVhkMVFnNER2VkNLb0NoTDZiV1ZKLWZsYWFIVVVMcVNUakRYSXJOblJQLUtwSnpzR0czZFAzWVE?oc=5","Tue, 29 Sep 2026 13:09:10 GMT","Why Waltz Health, Fresenius Kabi Are Taking Biosimilars Direct Pharmaceutical Commerce",{"title":222,"link":223,"pubDate":224,"description":225,"source":192},"Cigna Group (CI) Could Be 58% Undervalued On PBM And Claims Review Concerns - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Sat, 03 Oct 2026 15:36:30 GMT","Cigna Group (CI) Could Be 58% Undervalued On PBM And Claims Review Concerns Simply Wall Street",{"title":227,"link":228,"pubDate":229,"description":230,"source":198},"What Oura’s IPO could mean for digital health - Modern Healthcare","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiiAFBVV95cUxOSEExMkpjWnJ4WUtkYjlEa1dQUnYzWm5PWEl2NjVONTZmMWNYU01XclRoRDRzTFZQRHZQQUJSZG1Gd255RkplNU5kV2hxTEJPZk4ta0p4NXE4LW1OdWhJU2JCeFAtY0wyY2hYeGpfX1FVOXZxNFIzY1VwNjNNb2pmbDhjejczSG1V?oc=5","Tue, 29 Sep 2026 11:15:00 GMT","What Oura’s IPO could mean for digital health Modern Healthcare",{"title":232,"link":233,"pubDate":234,"description":235,"source":180},"Ibogaine has no therapeutic approval. Psyence Biomedical (PBM) unit signs a U.S. manufacturing deal. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuAFBVV95cUxOX1prOTdpNkpmSGRMMmFGc21zWF9UZU15OGQ1TncwV1gzTnM1TWZPMkFoZlJsUFk1dHQtSXZvY294M3dLUTFHM2hULWJhTXdyS2ZMR3RRZWZHcGxka0l3Y0xLaDFOMy1oR1FFRVNGbkJMNzZacWRkTUk1UE04a0xFVjJCNGVqWktHcS1USGp5ZGJZZTh6UVVxa3NRaDBRbnNJRVNfOGdXSTVxTmtBNFViQm14d0o4Y0hH?oc=5","Mon, 05 Oct 2026 11:00:28 GMT","Ibogaine has no therapeutic approval. Psyence Biomedical (PBM) unit signs a U.S. manufacturing deal. Stock Titan",{"title":237,"link":238,"pubDate":239,"description":240,"source":186},"GLP-1 Payment Risks: What Pharmacies Should Review with Their Processor - Pharmaceutical Commerce","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitAFBVV95cUxNMTI4YzUzLXJJMENsT092X2RUdnE0c3hyMlFiNnhNZEh3UXd6ajhSTm9jUFlNTjJCaENhTjRLTFZSWUdsdFNod2tIbUlJdkd2THpMVWk4bllfVDBCMG16Yjc4ZDVUNkRXSm04U0QzNUxWQ0UyTTc4Tl83ejZQeW50bTFNXzE4MFg1Z3Y5MExFYUVBNGdScHFDNTdpWUs0c2ZqY2JvWlVOSGYzN3hjYnNIODhvNUY?oc=5","Wed, 30 Sep 2026 02:44:37 GMT","GLP-1 Payment Risks: What Pharmacies Should Review with Their Processor Pharmaceutical Commerce",{"title":242,"link":243,"pubDate":244,"description":245,"source":180},"A deal with a shareholder would give Psyence Biomedical’s (PBM) subsidiary exclusive U.S. ibogaine rights. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuAFBVV95cUxPOG1tZmo5Q25tdUNpSldkRGg3YjhVRm1VV2NKSWVZMUthWFhOOWtIUFE3S0JJdW8zWEx5YU9KS3JMUXN1MFZsXzVORC0zWHB4NzBMZFVxZ2ViLUJnQlZveXcyN0tqMktoM0txeExEcFJ2ZTQ5T2FrNHF2cHZUMEc4YXlkRkUwRzJ2Zms5TGMzUTl2dW5XWG1kaFNoT1E5VlFyRTBuNG94czNiTHZtN3JDTmRLN0ZSVWZa?oc=5","Mon, 28 Sep 2026 11:00:44 GMT","A deal with a shareholder would give Psyence Biomedical’s (PBM) subsidiary exclusive U.S. ibogaine rights. Stock Titan",{"title":247,"link":248,"pubDate":249,"description":250,"source":180},"SEC Filings for Oct 5, 2026 - 10-K, 10-Q, 8-K Forms - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiaEFVX3lxTE9vWC1TQTFCUlhjbUF2Zm95MWxiVHo0ZVhoRkR1aV9tcEtKVkZOcEVMNEpEamZUZUY3Q25jWlpUaVk5RWNQRE5FWWthRml0a1NCS0JIUHgybm1BVHhBRi1ZSEtRdnJLNmQw?oc=5","Mon, 05 Oct 2026 23:22:27 GMT","SEC Filings for Oct 5, 2026 - 10-K, 10-Q, 8-K Forms Stock Titan",{"title":252,"link":253,"pubDate":254,"description":255,"source":192},"CVS Health (CVS) On New Distribution Deals And Why The Stock Still Looks Undervalued - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Tue, 06 Oct 2026 21:34:57 GMT","CVS Health (CVS) On New Distribution Deals And Why The Stock Still Looks Undervalued Simply Wall Street",{"title":257,"link":258,"pubDate":259,"description":260,"source":192},"How Data Lawsuit Settlement Will Impact CVS Health Stock Investors - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Mon, 28 Sep 2026 09:59:44 GMT","How Data Lawsuit Settlement Will Impact CVS Health Stock Investors Simply Wall Street",{"title":262,"link":263,"pubDate":264,"description":265,"source":192},"Distribution Deal Extension Could Be A Big Deal For CVS Stock (CVS) - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixwFBVV95cUxQc3k1MTVITEZEaFVxaVBDdjVldVdIMTN0STRqOFVnQWI4cmluYmptTzMxRGx6TkdTbW1ZN0JtbTVNSUEzVEdfQUhHVDR3dW1Vb1UzUndSQ2U5ZDA2Wk1qQ2ZReUdxV2Jkdkw0ZTNuNjZfemFfelQ4Vl94SVBIZTJjanF5NkMya2VoeXpUUEFmUTNGUE0xRTVsWTFUeDRNSldMRHdXZmtCREZzN2tkMF9IUk5jamd0Szl0WU9OVUxjdzhTV01faWZR0gHMAUFVX3lxTE51RExUb2xaVUh5TDRRUmRod1Bsa0tKVm44amszS1RMXy1RQ0wxcFpuYnZ3YjY1a1FLTFlvdTNPcFVYVDV2MDlPV25jdjUzV28yLWNZOS1CelQ2ZnBkM0ZtSGhIZXlXUXgweTB5UXJlMlpHM2g0TE1yTHJWamk3U1p3Y3dJZmJkRUhPQkJGTWVTbzFBRmlta05jdlJxa0pEeVc5cFU4a0U5V3RoYXFVeGFlNGpKYTE1Y21HR2ZOd29hbE13TnBUZ3Q1X3dQYg?oc=5","Mon, 05 Oct 2026 15:32:25 GMT","Distribution Deal Extension Could Be A Big Deal For CVS Stock (CVS) Simply Wall Street",{"title":267,"link":268,"pubDate":269,"description":270,"source":271},"Cigna Corp (CI) Stock Price Today: $273.75 - Pluang","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiV0FVX3lxTE1vWV9KV0JqZWN3UjBUT2dyZ1dvY3IyT0NYZllDVXZYMDRvVjRJeDcxTWp4QzBvZjREeFdNeHFoLWZwNVVjQWk0THNIel93bG1CbkNRbXEtcw?oc=5","Tue, 06 Oct 2026 21:49:22 GMT","Cigna Corp (CI) Stock Price Today: $273.75 Pluang","Pluang",{"title":273,"link":274,"pubDate":275,"description":276,"source":277},"Rightway Eyes IPO After $1.75B Valuation - Briefs Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMikgFBVV95cUxQN1NEd0FoQzV2dzBSa0syMVd4d2JRcUk0Sk1FTEFnTFJSY1lTWGJUbmtycVVKMzFQb0VQc2pJVzdadEZwUF9qWVhQVEkzT0hsRC1TZnVoYk9kSkpNSC1qRUlROXJYT2VRTTlTQ0tXbUk1UXFqZE5MbkgtQkRmRVZWTDcyUGtUcnpUdmd1djJ4V1Y3UQ?oc=5","Thu, 24 Sep 2026 07:00:00 GMT","Rightway Eyes IPO After $1.75B Valuation Briefs Finance","Briefs Finance",{"title":279,"link":280,"pubDate":281,"description":282,"source":198},"Medicare Advantage insurers pull back even further - Modern Healthcare","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMihgFBVV95cUxPU2FFdEh5bm4wREpWR3d0SUF3YlhnTlVNQUdZU0VCeWJuaWJQeVM4YVhJQnM1Q2J0ZnRTckFHRkxBcFdNUkFOS0c5cERQcWxEbjMxTVZwRHFKV2tENlphc28yMTUxTXF4bjJhenRQQmlyY3EwVG42NkFmeG9CUXIycTU5MjBUZw?oc=5","Tue, 29 Sep 2026 17:36:00 GMT","Medicare Advantage insurers pull back even further Modern Healthcare"]